Analgesics - Pakistan

  • Pakistan
  • In 2024, revenue in the Analgesics market in Pakistan amounts to US$123.40m.
  • The market is expected to grow annually by 6.90% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue with US$7,243.00m in 2024.
  • In relation to the total population of Pakistan, per person revenues amount to US$0.50 in 2024.
  • The demand for analgesics in Pakistan has seen a significant increase due to the growing prevalence of chronic pain conditions among the population.

Key regions: Brazil, Europe, Germany, Canada, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Pakistan has been experiencing steady growth in recent years, driven by customer preferences for over-the-counter pain relief medications, along with local special circumstances and underlying macroeconomic factors.Customer preferences in Pakistan have been a key driver of the growth in the Analgesics market. Consumers in Pakistan have shown a preference for easily accessible and affordable pain relief medications. Over-the-counter analgesics, such as paracetamol and ibuprofen, are popular choices for self-medication due to their effectiveness in relieving common aches and pains. Additionally, the convenience of purchasing these medications without a prescription has contributed to their popularity among consumers.Trends in the market have also played a role in the growth of the Analgesics market in Pakistan. There has been an increasing demand for analgesics with additional benefits, such as those that also provide relief from cold and flu symptoms. This trend can be attributed to the high prevalence of respiratory infections in Pakistan, as well as the desire of consumers to find multi-purpose medications that address multiple symptoms simultaneously. Manufacturers have responded to this trend by introducing combination analgesics that provide relief from both pain and cold symptoms.Local special circumstances have further contributed to the growth of the Analgesics market in Pakistan. The country has a large population, which creates a significant market for pain relief medications. Additionally, the lack of access to healthcare facilities in remote areas of Pakistan has led to an increased reliance on over-the-counter analgesics for self-medication. This has driven the demand for these medications and contributed to the growth of the market.Underlying macroeconomic factors have also played a role in the development of the Analgesics market in Pakistan. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income among consumers. As a result, consumers have more purchasing power to spend on healthcare products, including pain relief medications. This has fueled the demand for analgesics in the market.In conclusion, the Analgesics market in Pakistan has been growing steadily due to customer preferences for over-the-counter pain relief medications, trends in the market, local special circumstances, and underlying macroeconomic factors. The convenience, affordability, and effectiveness of over-the-counter analgesics have made them a popular choice among consumers in Pakistan. The demand for analgesics with additional benefits, such as relief from cold and flu symptoms, has also contributed to the growth of the market. The large population and lack of access to healthcare facilities in remote areas have further driven the demand for over-the-counter analgesics. Finally, the steady economic growth in Pakistan has increased consumers' purchasing power and fueled the demand for pain relief medications.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)